Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Establishing a Comprehensive Database for Patients with Sickle Cell Disease in the State of Nebraska, the First Step of Improving Their Care

Omar Abughanimeh, MD, Mahammed Khan Suheb, MD, Steven Ebers, MD, Julie Eclov, MD PhD, Robin High, MBA, MA, Alex Nester, MD, Aleh Bobr, MD, Scott A Koepsell, MD, PhD, FCAP, James Harper, MD, Krishna Gundabolu, MBBS, Laxmi Narayana Buddharaju, MBBS

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-136297

Published: 2020

Journal Articles

Outcomes of Chronic Automated RBC Exchange Program in Omaha, Nebraska 2015-2020

Aleh Bobr, MD, Scott A Koepsell, MD, PhD, FCAP, Julie Eclov, MD PhD, Omar Abughanimeh, MD, Steven Ebers, MD, Mahammed Khan Suheb, MD, Robin High, MBA, MA, Alex Nester, MD, Krishna Gundabolu, MBBS, James Harper, MD, Laxmi Narayana Buddharaju, MBBS

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-136308

Published: 2020

Journal Articles

Outcomes of Red Cell Exchange in Pregnant Patients with Sickle Cell Disease: A Case Series

Mahammed Khan Suheb, MD, Omar Abughanimeh, MD, Steven Ebers, MD, Julie Eclov, MD PhD, Aleh Bobr, MD, Scott A Koepsell, MD, PhD, FCAP, Alex Nester, MD, James Harper, MD, Krishna Gundabolu, MBBS, Laxmi Narayana Buddharaju, MBBS

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-139892

Published: 2020

Journal Articles

Age-Based Probability of Ten-Year Overall Survival (OS) of Acute Myeloid Leukemia (AML): A National Cancer Database (NCDB) Analysis

Vijaya R. Bhatt, MD, Valerie K Shostrom, Nabin Khanal, MBBS, Chakra P Chaulagain, MD, Fiona He, MD, Krishna Gundabolu, MBBS

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-134434

Published: 2020

Journal Articles

Early Mortality and Overall Survival in Acute Promyelocytic Leukemia: Do Real-World Data Match Results of the Clinical Trials?

Prajwal Dhakal, MBBS, Elizabeth R. Lyden, MS, Venkat Rajasurya, MD, Krishna Gundabolu, MBBS, Chakra P Chaulagain, MD, Vijaya R. Bhatt, MD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-136186

Published: 2020

Journal Articles

Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)

Vijaya R. Bhatt, MD, Christopher Wichman, PhD, Zaid S. Al-Kadhimi, MD, Thuy T. Koll, MD, Ann Berger, PhD APRN-CNS, AOCNS, FAAN, James O. Armitage, MD, Sarah A. Holstein, MD PhD, Krishna Gundabolu, MBBS, Lori J. Maness, MD

Blood (2019) 134 (Supplement_1): 120.

https://doi.org/10.1182/blood-2019-124375

Published: 2019

Journal Articles

Prevalence and Effects of Polypharmacy on Overall Survival (OS) of Acute Myeloid Leukemia (AML)

Prajwal Dhakal, MBBS, Elizabeth R. Lyden, MS, Kate-Lynn E Muir, MD, Zaid S. Al-Kadhimi, MD, Thuy T. Koll, MD, Lori J. Maness, MD, Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MD

Blood (2019) 134 (Supplement_1): 5086.

https://doi.org/10.1182/blood-2019-124000

Published: 2019

Journal Articles

Phase 1b Study of the Epichaperome Inhibitor PU-H71 Administered Orally with Ruxolitinib Continuation for the Treatment of Patients with Myelofibrosis

Naveen Pemmaraju, MD, Krishna Gundabolu, MBBS, Kristen Pettit, MD, Moshe Talpaz, MD, Nikolai A. Podoltsev, MD PhD, Gary J. Schiller, MD, Peter Eisenberg, MD, Hagop Youssoufian, MD, Susan Duggan, RN, MBA, Barbara Wallner, PhD, Srdan Verstovsek, MD PhD

Blood (2019) 134 (Supplement_1): 4178.

https://doi.org/10.1182/blood-2019-130310

Published: 2019

Journal Articles

Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)

Vijaya R. Bhatt, MD, Valerie K Shostrom, Sarah A. Holstein, MD PhD, Zaid S. Al-Kadhimi, MD, Lori J. Maness, MD, Ann Berger, PhD APRN-CNS, AOCNS, FAAN, James O. Armitage, MD, Krishna Gundabolu, MBBS

Blood (2019) 134 (Supplement_1): 2155.

https://doi.org/10.1182/blood-2019-122679

Published: 2019

Journal Articles

Apixaban, Dalteparin, in Active Cancer Associated Venous Thromboembolism, the ADAM VTE Trial

Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD, Jennifer Le-Rademacher, PhD, Aneel A. Ashrani, MD, M.S., Alfonso J Tafur, MD MS, RPVI, FSVM, Krishna Gundabolu, MBBS, Juliana Perez-Botero, MD, Usha Perepu, MD, Daniel M. Anderson, MD MPH, Charles Kuzma, MD, Roberto leon Ferre, MD, Stanislav Henkin, MD, Charles Lenz, MD, Charles Loprinzi, MD

Blood (2018) 132 (Supplement 1): 421.

https://doi.org/10.1182/blood-2018-99-118808

Published: 2018

Journal Articles

Socioeconomic Factors Associated with Overall Survival (OS) in Adults with Acute Lymphoblastic Leukemia (ALL)

Jayadev Manikkam Umakanthan, MBBS, Baojiang Chen, Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MBBS

Blood (2017) 130 (Supplement 1): 3431.

https://doi.org/10.1182/blood.V130.Suppl_1.3431.3431

Published: 2017

Journal Articles

Treatment Practices in Older Adults with Acute Myeloid Leukemia (AML)

Andrea J. Lee, BS, Elizabeth R. Lyden, MS, Lakshmi Manogna Chintalacheruvu, MD, Thuy Thi Koll, MD, Lori J. Maness, MD, Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MD

Blood (2017) 130 (Supplement 1): 5659.

https://doi.org/10.1182/blood.V130.Suppl_1.5659.5659

Published: 2017

Journal Articles

Efficacy of Direct Oral Anticoagulants (DOAC) in Patients with Antiphospholipid Antibody Syndrome (APS)

Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MBBS, Matthew A. Lunning, DO, Muhamed Baljevic, MD

Blood (2017) 130 (Supplement 1): 4917.

https://doi.org/10.1182/blood.V130.Suppl_1.4917.4917

Published: 2017

Journal Articles

Practice Patterns of Allogeneic Hematopoietic Cell Transplantation (HCT) for Adults with Acute Lymphoblastic Leukemia (ALL)

Jayadev Manikkam Umakanthan, MBBS, Baojiang Chen, Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MD

Blood (2017) 130 (Supplement 1): 5013.

https://doi.org/10.1182/blood.V130.Suppl_1.5013.5013

Published: 2017

Journal Articles

Gender and Race As Prognostic Factors In Patients Treated With Rituximab For B-Cell Non-Hodgkin Lymphoma

Mendel Goldfinger, MD, Santiago Aparo, MD, Krishna Gundabolu, MBBS, MD, Stefan K Barta, MD, MS, MRCP

Blood (2013) 122 (21): 3053.

https://doi.org/10.1182/blood.V122.21.3053.3053

Published: 2013

Journal Articles

Extramedullary Leukemia Relapse In Patients With Acute Myeloid Leukemia Allogeneic Stem Cell Transplantation: Risk Factors and Prognosis

Vinay Gupta, MBBS, Krishna Gundabolu, MBBS, MD, Wilson I Gonsalves, MD, Mark R. Litzow, MD, William J Hogan, MD, Naseema Gangat, MBBS, Mrinal M Patnaik, MBBS

Blood (2013) 122 (21): 2081.

https://doi.org/10.1182/blood.V122.21.2081.2081

Published: 2013

Journal Articles

Dysregulation of TGF-Beta Stimulated Smad Signaling Is Seen in Myelodysplasia and Points to the Potential Therapeutic Efficacy of TGF-Beta Receptor I Kinase Inhibition in Low Grade Disease.

Blood (2009) 114 (22): 737.

https://doi.org/10.1182/blood.V114.22.737.737

Published: 2009

NARROW

Establishing a Comprehensive Database for Patients with Sickle Cell Disease in the State of Nebraska, the First Step of Improving Their Care

Outcomes of Chronic Automated RBC Exchange Program in Omaha, Nebraska 2015-2020

Outcomes of Red Cell Exchange in Pregnant Patients with Sickle Cell Disease: A Case Series

Age-Based Probability of Ten-Year Overall Survival (OS) of Acute Myeloid Leukemia (AML): A National Cancer Database (NCDB) Analysis

Early Mortality and Overall Survival in Acute Promyelocytic Leukemia: Do Real-World Data Match Results of the Clinical Trials?

Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)

Prevalence and Effects of Polypharmacy on Overall Survival (OS) of Acute Myeloid Leukemia (AML)

Phase 1b Study of the Epichaperome Inhibitor PU-H71 Administered Orally with Ruxolitinib Continuation for the Treatment of Patients with Myelofibrosis

Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)

Apixaban, Dalteparin, in Active Cancer Associated Venous Thromboembolism, the ADAM VTE Trial

Socioeconomic Factors Associated with Overall Survival (OS) in Adults with Acute Lymphoblastic Leukemia (ALL)

Treatment Practices in Older Adults with Acute Myeloid Leukemia (AML)

Efficacy of Direct Oral Anticoagulants (DOAC) in Patients with Antiphospholipid Antibody Syndrome (APS)

Practice Patterns of Allogeneic Hematopoietic Cell Transplantation (HCT) for Adults with Acute Lymphoblastic Leukemia (ALL)

Gender and Race As Prognostic Factors In Patients Treated With Rituximab For B-Cell Non-Hodgkin Lymphoma

Extramedullary Leukemia Relapse In Patients With Acute Myeloid Leukemia Allogeneic Stem Cell Transplantation: Risk Factors and Prognosis

Dysregulation of TGF-Beta Stimulated Smad Signaling Is Seen in Myelodysplasia and Points to the Potential Therapeutic Efficacy of TGF-Beta Receptor I Kinase Inhibition in Low Grade Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only